Replies to post #213389 on Biotech Values

[mcbio]

MGNX -

The number of =>G3 tox events gave me pause, though. What about you?

While there were =>G3 AEs in 36% of patients, the abstract also noted that an LID strategy and early use of tocilizumab ameliorated this toxicity and limited corticosteroid use.